TrialMenopause (New York, N.Y.)2013

Relapse of vasomotor symptoms after discontinuation of the selective serotonin reuptake inhibitor escitalopram: results from the menopause strategies: finding lasting answers for symptoms and health research network.

Hadine Joffe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.